financetom
Business
financetom
/
Business
/
Genpact Q4 Adjusted Net Income, Revenue Rise; Sets Q1, 2025 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Genpact Q4 Adjusted Net Income, Revenue Rise; Sets Q1, 2025 Outlook
Feb 6, 2025 2:01 PM

04:32 PM EST, 02/06/2025 (MT Newswires) -- Genpact ( G ) reported Q4 adjusted net income late Thursday of $0.91 per diluted share, up from $0.82 a year earlier.

Analysts polled by FactSet expected $0.86.

Revenue for the quarter ended Dec. 31 was $1.25 billion, compared with $1.15 billion a year earlier.

Analysts expected $1.23 billion.

For Q1, the professional services company is projecting adjusted earnings of $0.79 to $0.80 on revenue of $1.20 billion to $1.21 billion.

Analysts are looking for $0.78 and $1.20 billion, respectively.

For 2025, the company is projecting adjusted EPS of $3.52 to $3.59 on revenue of $5.03 billion to $5.13 billion.

Analysts are looking for $3.51 and $5.05 billion, respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SLB to buy ChampionX for $8 billion in energy sector consolidation
SLB to buy ChampionX for $8 billion in energy sector consolidation
Apr 2, 2024
(Reuters) -Top oilfield services company SLB said on Tuesday it will buy smaller rival ChampionX in an all-stock deal valued at $7.75 billion, amid growing consolidation in the North American energy sector. Oilfield services companies have followed energy producers in pursuing deals, as they navigate operational and pricing challenges and cater to customers who have cut spending on new wells...
Top Premarket Decliners
Top Premarket Decliners
Apr 2, 2024
07:57 AM EDT, 04/02/2024 (MT Newswires) -- Acorda Therapeutics' ( ACOR ) shares slumped 76% Tuesday premarket after saying it signed a deal to sell substantially all its assets and that it initiated Chapter 11 bankruptcy proceedings. Verve Therapeutics ( VERV ) shares fell 34% after the company said it has decided to pause enrollment in its Heart-1 clinical trial...
Top Premarket Gainers
Top Premarket Gainers
Apr 2, 2024
07:50 AM EDT, 04/02/2024 (MT Newswires) -- XTI Aerospace ( XTIA ) shares were up nearly 90% in recent Tuesday premarket activity, extending Monday's rally. Ashford (AINC) stock was 64% higher after the company said overnight its board approved a plan to terminate Ashford's common stock registration and to delist from the NYSE American. Kidpik ( PIK ) shares were...
Cimpress Insider Sold Shares Worth $511,286, According to a Recent SEC Filing
Cimpress Insider Sold Shares Worth $511,286, According to a Recent SEC Filing
Apr 2, 2024
07:57 AM EDT, 04/02/2024 (MT Newswires) -- Florian Baumgartner, EVP and CEO, Vista, on April 01, 2024, sold 5,683 shares in Cimpress ( CMPR ) for $511,286. Following the Form 4 filing with the SEC, Baumgartner has control over a total of 33,793 shares of the company, with 33,793 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1262976/000126297624000023/xslF345X03/wk-form4_1712010010.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved